It has been further suggested that a balance between STAT1, STAT3, and STAT5 expression, upon interferon-mediated activation, impact the heterodimerization and transcriptional mechanisms driven by JAK-STAT activation in melanoma [231,232]. The gene discussed is STAT1; the disease is melanoma.